Bank of New York Mellon Corp decreased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.7% in the 3rd quarter, Holdings Channel reports. The firm owned 11,460,306 shares of the healthcare conglomerate’s stock after selling 439,304 shares during the period. UnitedHealth Group accounts for approximately 0.6% of Bank of New York Mellon Corp’s portfolio, making the stock its 23rd biggest position. Bank of New York Mellon Corp’s holdings in UnitedHealth Group were worth $2,244,501,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in UNH. Jennison Associates LLC raised its position in UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after acquiring an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC raised its position in UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. raised its position in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares in the last quarter. Parametric Portfolio Associates LLC raised its position in UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after acquiring an additional 1,562,661 shares in the last quarter. Finally, Thrivent Financial For Lutherans raised its position in UnitedHealth Group by 346.7% during the second quarter. Thrivent Financial For Lutherans now owns 1,690,187 shares of the healthcare conglomerate’s stock worth $313,394,000 after acquiring an additional 1,311,773 shares in the last quarter. Institutional investors and hedge funds own 86.01% of the company’s stock.

In related news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,630 shares of company stock worth $7,669,416. 0.89% of the stock is owned by insiders.

Several analysts have issued reports on the stock. Leerink Swann reaffirmed a “buy” rating and set a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price target on the stock in a research report on Thursday, September 21st. Cantor Fitzgerald upped their price target on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Oppenheimer upped their price target on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Finally, Wells Fargo & Co reaffirmed an “outperform” rating and set a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Three research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $229.54.

UnitedHealth Group Inc (NYSE UNH) opened at $228.64 on Monday. The firm has a market cap of $221,060.00, a PE ratio of 25.98, a PEG ratio of 1.56 and a beta of 0.66. UnitedHealth Group Inc has a 1 year low of $156.09 and a 1 year high of $231.77. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same period last year, the firm earned $2.17 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. sell-side analysts predict that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2018/01/15/bank-of-new-york-mellon-corp-sells-439304-shares-of-unitedhealth-group-inc-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related stocks with our FREE daily email newsletter.